Management of food-induced anaphylaxis: Unsolved challenges

Current Clinical Pharmacology

Volumn 4, Issue 2, 2009, Pages 113-125

  Arias, Katherine ^a   Waserman, Susan ^b   Jordana, Manel ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Acute management; Anaphylaxis; Food allergy; Long term management; Measures

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CORTICOSTEROID; DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; METARAMINOL; METHYLPREDNISOLONE; NORADRENALIN; PREDNISONE; VASOPRESSIN;

AIRWAY OBSTRUCTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG MECHANISM; EMERGENCY CARE; EMPOWERMENT; FLUID RESUSCITATION; FOOD ALLERGY; HEALTH EDUCATION; HUMAN; HYPOTENSION; IMMUNOPATHOGENESIS; INFORMATION DISSEMINATION; LABORATORY DIAGNOSIS; LEGAL ASPECT; LONG TERM CARE; NONHUMAN; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SELF INJECTION; SHOCK; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; URTICARIA;

ANAPHYLAXIS; ANIMALS; BIOLOGICAL MARKERS; EMERGENCY MEDICAL SERVICES; FOOD HYPERSENSITIVITY; GUIDELINE ADHERENCE; HUMANS; INFORMATION DISSEMINATION; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 68449094942     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488409788184981     Document Type: Review

References (120)

1. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117(2): 391-7.
2. Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 2006; 117(2): 367-77.
3. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115(3 Suppl 2): S483-523.
4. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108(5): 861-6.
5. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114(2): 371-6.
6. Kemp SF, Lockey RF, Wolf BL, Lieberman P. Anaphylaxis: a review of 266 cases. Arch Intern Med 1995; 155(16): 1749-54.
7. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006; 97(1): 39-43.
8. Braganza SC, Acworth JP, McKinnon DR, Peake JE, Brown AF. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91(2): 159-63.
9. Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62(8): 857-71.
10. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327(6): 380-4.
11. Pumphrey RS, Stanworth SJ. The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy 1996; 26(12): 1364-70.
12. Klein JS, Yocum MW. Underreporting of anaphylaxis in a community emergency room. J Allergy Clin Immunol 1995; 95(2): 637-8.
13. Lieberman P, Camargo CA, Jr., Bohlke K, et al. Epidemiology of anaphylaxis: findings of the american college of allergy, asthma and immunology epidemiology of anaphylaxis working group. Ann Allergy Asthma Immunol 2006; 97(5): 596-602.
14. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001; 161(1): 15-21.
15. Weiler JM. Anaphylaxis in the general population: a frequent and occasionally fatal disorder that is underrecognized. J Allergy Clin Immunol 1999; 104(2 Pt 1): 271-3.
16. Cohen SG, Zelaya-Quesada M. Portier, Richet, and the discovery of anaphylaxis: a centennial. J Allergy Clin Immunol 2002; 110(2): 331-6.
17. Finkelman FD. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 2007; 120(3): 506-15; quiz 516-7.
18. Sun J, Arias K, Alvarez D, et al. Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses. J Immunol 2007; 179(10): 6696-703.
19. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002; 2(10): 773-86.
20. Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185(4): 663-72.
21. Hua X, Kovarova M, Chason KD, et al. Enhanced mast cell activation in mice deficient in the A2b adenosine receptor. J Exp Med 2007; 204(1): 117-28.
22. Olivera A, Mizugishi K, Tikhonova A, et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 2007; 26(3): 287-97.
23. Bashir ME, Louie S, Shi HN, Nagler-Anderson C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 2004; 172(11): 6978-87.
24. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002; 110(3): 341-8.
25. Simons FE 9. Anaphylaxis. J Allergy Clin Immunol 2008; 121(2 Suppl): S402-7; quiz S420.
26. Smith PL, Kagey-Sobotka A, Bleecker ER, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66(5): 1072-80.
27. Lenchner K, Grammer LC. A current review of idiopathic anaphylaxis. Curr Opin Allergy Clin Immunol 2003; 3(4): 305-11.
28. Ring J, Darsow U. Idiopathic anaphylaxis. Curr Allergy Asthma Rep 2002; 2(1): 40-5.
29. Bruhns P, Fremont S, Daeron M. Regulation of allergy by Fc receptors. Curr Opin Immunol 2005; 17(6): 662-9.
30. Kraft S, Kinet JP. New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 2007; 7(5): 365-78.
31. Kraft S, Novak N. Fc receptors as determinants of allergic reactions. Trends Immunol 2006; 27(2): 88-95.
32. Soreide E, Buxrud T, Harboe S. Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment. Acta Anaesthesiol Scand 1988; 32(4): 339-42.
33. Viner NA, Rhamy RK. Anaphylaxis manifested by hypotension alone. J Urol 1975; 113(1): 108-10.
34. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004; 4(4): 285-90.
35. Tang AW. A practical guide to anaphylaxis. Am Fam Physician 2003; 68(7): 1325-32.
36. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. CMAJ 2003; 169(4): 307-11.
37. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics 2003; 111(6 Pt 3): 1601-8.
38. Brady WJ, Jr., Luber S, Carter CT, Guertler A, Lindbeck G. Multiphasic anaphylaxis: an uncommon event in the emergency department. Acad Emerg Med 1997; 4(3): 193-7.
39. Brazil E, MacNamara AF. "Not so immediate" hypersensitivity - the danger of biphasic anaphylactic reactions. J Accid Emerg Med 1998; 15(4): 252-3.
40. Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 2007; 98(1): 64-9.
41. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005; 95(3): 217-26; quiz 226, 258.
42. Kemp SF. The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms? Curr Allergy Asthma Rep 2008; 8(1): 45-8.
43. Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000; 106(4): 762-6.
44. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 2005; 28(4): 381-8.
45. Lantner R, Reisman RE. Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol 1989; 84(6 Pt 1): 900-6.
46. Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 2003; 33(8): 1033-40.
47. Hourihane JO, Grimshaw KE, Lewis SA, et al. Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community? Clin Exp Allergy 2005; 35(9): 1227-33.
48. Vander Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 2000; 137(6): 749-55.
49. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107(1): 191-3.
50. Sampson HA. Fatal food-induced anaphylaxis. Allergy 1998; 53(46 Suppl): 125-30.
51. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30(8): 1144-50.
52. Miller MM, Miller MM. Beta-blockers and anaphylaxis: are the risks overstated? J Allergy Clin Immunol 2005; 116(4): 931-3; author reply 933-6.
53. Bahna SL. Clinical expressions of food allergy. Ann Allergy Asthma Immunol 2003; 90(6 Suppl 3): 41-4.
54. Sampson HA 9. Food allergy. J Allergy Clin Immunol 2003; 111(2 Suppl): S540-7.
55. Matasar MJ, Neugut AI. Epidemiology of anaphylaxis in the United States. Curr Allergy Asthma Rep 2003; 3(1): 30-5.
56. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in olmsted county: A population-based study. J Allergy Clin Immunol 1999; 104(2 Pt 1): 452-6.
57. Rona RJ, Keil T, Summers C, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol 2007; 120(3): 638-46.
58. Wang J, Sampson HA. Food anaphylaxis. Clin Exp Allergy 2007; 37(5): 651-60.
59. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119(4): 1016-8.
60. Clark S, Bock SA, Gaeta TJ, et al. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 2004; 113(2): 347-52.
61. Skripak JM, Matsui EC, Mudd K, Wood RA. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2007; 120(5): 1172-7.
62. Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J Allergy Clin Immunol 2007; 120(6): 1413-7.
63. Hourihane JO, Roberts SA, Warner JO. Resolution of peanut allergy: case-control study. BMJ 1998; 316(7140): 1271-5.
64. Skolnick HS, Conover-Walker MK, Koerner CB, et al. The natural history of peanut allergy. J Allergy Clin Immunol 2001; 107(2): 367-74.
65. Savage JH, Limb SL, Brereton NH, Wood RA. The natural history of peanut allergy: extending our knowledge beyond childhood. J Allergy Clin Immunol 2007; 120(3): 717-9.
66. Greer FR, Sicherer SH, Burks AW. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008; 121(1): 183-91.
67. Lack G. Epidemiologic risks for food allergy. J Allergy Clin Immunol 2008; 121(6): 1331-6.
68. Lack G, Fox D, Northstone K, Golding J. Factors associated with the development of peanut allergy in childhood. N Engl J Med 2003; 348(11): 977-85.
69. Sicherer SH, Sampson HA. Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 2007; 120(3): 491-503; quiz 504-5.
70. Burks W, Bannon GA, Sicherer S, Sampson HA. Peanut-induced anaphylactic reactions. Int Arch Allergy Immunol 1999; 119(3): 165-72.
71. Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119(4): 1018-9.
72. Yu JW, Kagan R, Verreault N, et al. Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol 2006; 118(2): 466-72.
73. Dalal I, Binson I, Reifen R, et al. Food allergy is a matter of geography after all: sesame as a major cause of severe IgE-mediated food allergic reactions among infants and young children in Israel. Allergy 2002; 57(4): 362-5.
74. Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children - a questionnaire-based survey in Germany. Allergy 2005; 60(11): 1440-5.
75. Novembre E, Cianferoni A, Bernardini R, et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics 1998; 101(4): E8.
76. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004; 257: 116-28; discussion 128-32, 157-60, 276-85.
77. Uguz A, Lack G, Pumphrey R, et al. Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign. Clin Exp Allergy 2005; 35(6): 746-50.
78. Lin RY, Schwartz LB, Curry A, et al. Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 2000; 106(1 Pt 1): 65-71.
79. Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007; 120(1 Suppl): S2-24.
80. Sampson HA, Jolie PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984; 311(6): 372-6.
81. Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 358(1): 28-35.
82. Denzlinger C, Haberl C, Wilmanns W. Cysteinyl leukotriene production in anaphylactic reactions. Int Arch Allergy Immunol 1995; 108(2): 158-64.
83. Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 2007; 62(8): 838-41.
84. Nurmatov U, Worth A, Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol 2008; 122(2): 353-61, 361 e1-3.
85. Tse Y, Rylance G. Emergency management of anaphylaxis in children and young people: new guidance from the Resuscitation Council (UK). Arch Dis Child 2008.
86. Sicherer SH, Simons FE. Self-injectable epinephrine for first-aid management of anaphylaxis. Pediatrics 2007; 119(3): 638-46.
87. Emergency medical treatment of anaphylactic reactions. Project Team of The Resuscitation Council (UK). Resuscitation 1999; 41(2): 93-9.
88. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 101(1 Pt 1): 33-7.
89. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108(5): 871-3.
90. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005; 5(4): 359-64.
91. Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004; 21(2): 149-54.
92. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003; 97(5): 1381-95.
93. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005; 112(24 Suppl): IV1-203.
94. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986; 14(1): 17-21.
95. Sheikh A, ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2007; (1): CD006160.
96. Simons FE. Advances in H1-antihistamines. N Engl J Med 2004; 351(21): 2203-17.
97. Douglas DM, Sukenick E, Andrade WP, Brown JS. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol 1994; 93(6): 977-85.
98. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78(1 Pt 1): 76-83.
99. Choo K, Sheikh A. Action plans for the long-term management of anaphylaxis: systematic review of effectiveness. Clin Exp Allergy 2007; 37(7): 1090-4.
100. Furlong TJ, DeSimone J, Sicherer SH. Peanut and tree nut allergic reactions in restaurants and other food establishments. J Allergy Clin Immunol 2001; 108(5): 867-70.
101. Simons E, Weiss CC, Furlong TJ, Sicherer SH. Impact of ingredient labeling practices on food allergic consumers. Ann Allergy Asthma Immunol 2005; 95(5): 426-8.
102. Kelso JM. A second dose of epinephrine for anaphylaxis: how often needed and how to carry. J Allergy Clin Immunol 2006; 117(2): 464-5.
103. Korenblat P, Lundie MJ, Dankner RE, Day JH. A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed? Allergy Asthma Proc 1999; 20(6): 383-6.
104. Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 2000; 105(2): 359-62.
105. Song TT, Nelson MR, Chang JH, Engler RJ, Chowdhury BA. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 2005; 94(5): 539-42.
106. Simons FE, Gu X, Johnston LM, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics 2000; 106(5): 1040-4.
107. Rawas-Qalaji MM, Simons FE, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol 2006; 117(2): 398-403.
108. Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004; 113(5): 837-44.
109. Stewart AG, Ewan PW. The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department. QJM 1996; 89(11): 859-64.
110. Schwartz HJ. Acute allergic disease in a hospital emergency room: a retrospective evaluation of one year's experience. Allergy Proc 1995; 16(5): 247-50.
111. Bellou A, Manel J, Samman-Kaakaji H, et al. Spectrum of acute allergic diseases in an emergency department: an evaluation of one years' experience. Emerg Med (Fremantle) 2003; 15(4): 341-7.
112. Reznek M, Smith-Coggins R, Howard S, et al. Emergency medicine crisis resource management (EMCRM): pilot study of a simulation-based crisis management course for emergency medicine. Acad Emerg Med 2003; 10(4): 386-9.
113. Clark S, Camargo CA, Jr. Emergency management of food allergy: systems perspective. Curr Opin Allergy Clin Immunol 2005; 5(3): 293-8.
114. Vukmir RB, Kremen R, Ellis GL, et al. Compliance with emergency department referral: the effect of computerized discharge instructions. Ann Emerg Med 1993; 22(5): 819-23.
115. Zonfrillo MR, Mello MJ, Palmisciano LM. Usefulness of computerized pediatric motor vehicle safety discharge instructions. Acad Emerg Med 2003; 10(10): 1131-3.
116. Lieberman P, Decker W, Camargo CA, Jr., et al. SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department. Ann Allergy Asthma Immunol 2007; 98(6): 519-23.
117. Avery NJ, King RM, Knight S, Hourihane JO. Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol 2003; 14(5): 378-82.
118. Marklund B, Ahlstedt S, Nordstrom G. Health-related quality of life in food hypersensitive schoolchildren and their families: parents' perceptions. Health Qual Life Outcomes 2006; 4: 48.
119. Primeau MN, Kagan R, Joseph L, et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000; 30(8): 1135-43.
120. Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 2001; 87(6): 461-4.